Pages: 37 - 39
Authors: Tkachuk N. P., Sheremet M. I., Gyrla Y. V., Bilookyi V. V.
Abstract: The paper presents some data about a monitoring of the changes in the thyroid residue: hormonal status, antibody rate depending on the scope of nodular goiter surgical treatment. It was established that 2 months after the surgery the autoimmune process becomes more active, the intensity of which gradually fades to the 6th and 12th months of post-operative intervention. It should be noted that a compensatory growth of the residual thyroid tissue after the surgery was observed.
Keywords: Thyroid gland, surgical interventions, monitoring of patients
1. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association
Мedical guidelines for clinical practice for the diagnosis and management of thyroid nodules/H. Gharib, E. Papini,
R. Paschke [et al.] (AACE/AME/ETA Task Force on Thyroid Nodules)//Endocr. Pract. – 2010. – Vol. 16 (1). – P. 1–43.
2. Bilateral subtotal thyroidectomy versus hemithyroidectomy plus subtotal resection (Dunhill Procedure) for begign goiter:
long-term results of a prospective, randomized study/N. Rayes, T. Steinmuller, S. Schroder [et al.]//World Journal of
Surgery. – 2013. – Vol. 37, № 1. – P. 84–90.
The main principle of the oriental medicine – the issues of health preservation in the works of Avicenna
3. Dralle H. State of the art: surgery for endemic goiter – a plea for individualizing the extent of resection instead of heading
for routine total thyroidectomy/H. Dralle, K. Lorenz, A. Machens//Langenbeck’s Archives of Surgery. – 2011. – Vol. 396,
№ 8. – P. 1137–1143.
4. Five-year follow-up of a randomized clinical trial of total thyroidectomy versus dunhill operation versus bilateral subtotal
thyroidectomy for multinodular nontoxic goiter/A. Hubalewska-Dydejczyk, F. Golkowski, S. Cichoń [et al.]//World
Journal of Surgery. – 2010. – Vol. 34, № 6. – P. 1203–1213.
5. González C. Morbidity following thyroid surgery: does surgeon volume matter?/C. González, G. Franch-Arcas, A. Gómez-
Alonso//Langenbeck’s Archives of Surgery. – 2013. – Vol. 398, № 3. – P. 419–422.
6. Moalem J. Treatment and prevention of recurrence of multinodular goiter: an evidence-based review of the
literature/J. Moalem, I. Suh, Q. Duh//World Journal of Surgery. – 2008. – Vol. 32, № 7. – P. 1301–1312.
7. Nodular recurrence and hypothyroidism following partial thyroidectomy for benign nodular thyroid disease in
children and adolescents/M. Akkari, D. Schmitt, C. Jeandel [et al.]//J. Pediatr. Otorhinolaryngol. – 2014. – Vol. 8,
№ 78 (10). – P. 1742–1746.
8. Rayes N. The surgical treatment of bilateral benign nodular goiter/N. Rayes, D. Seehofer, P. Neuhaus//Deutsches Ärzteblatt
International. – 2014. – Vol. 111, № 10. – P. 171–178.
9. Reference interval of thyroid stimulating hormone and free thyroxine in a reference population over 60 years old and in very
old subjects (over 80 years): comparison to young subjects/R. Fontes, C. R. Coeli, F. Aguiar [et al.]//Thyroid Research. –
2013. – Vol. 6, № 13. – P. 125–136.
10. Risk factors in reoperative thyroid surgery for recurrent goitre. Our experience/P. G. Calo, G. Pisano, F. Medas [et al.]//
G. Chir. – 2012. – Vol. 33, № 10. – P. 335–338.
11. Sabra M. Stimulated thyroglobulin levels obtained after thyroidectomy are a good indicator for risk of future recurrence
from thyroid pathology/M. Sabra//Clinical thyroidology for patients. – 2013. – Vol. 6, № 8. – P. 8–9.